Pramlintide 	Placebo	Weight 	-1	-1	patients who received pramlintide lost weight, whereas those who received placebo gained weight,
Pramlintide 	Placebo	Weight 	846	943	pramlintide resulted in greater reductions in glycated hemoglobin (HbA1c) and weight than placebo
Pramlintide 	Placebo	Severe hypoglycemia 	1390	1466	Event rates for severe hypoglycemia were similar for pramlintide and placebo
Pramlintide 	Placebo	Glycated hemoglobin	-1	-1	Regardless of duration of diabetes tertile, patients who received pramlintide experienced greater reductions in HbA1c compared with those receiving placebo (Fig. 1a). Moreover, patients who received pramlintide lost weight, whereas those who received placebo gained weight
Pramlintide 	Placebo	Weight 	-1	-1	<td align="left">Weight, kg, mean (SD)</td><td align="char" char="(">76.6 (13.9)</td><td align="char" char="(">77.0 (14.3)</td><td align="char" char="(">74.4 (14.4)</td><td align="char" char="(">72.9 (12.9)</td><td align="char" char="(">76.7 (14.8)</td><td align="char" char="(">76.3 (14.8)</td>
